Businessman tries his luck at building pot brand

by Gene Johnson

(AP)—The plans of a former Microsoft manager to create the "Starbucks of Pot" are worrying other activists who pushed for the legalization of marijuana in Washington state.

They say Jamen Shively's ambitions don't merely raise questions about whether big corporations will come to dominate the legal pot industry, but also about whether his profit-driven approach might cause a backlash that could slow the marijuana reform movement across the country.

Shively is trying to raise $10 million from investors and eventually wants to build his company, Diego Pellicer (pay-EE'-sehr), into an international pot powerhouse.

But the states aren't licensing marijuana stores yet. say the way Shively is going about making deals with dispensaries could risk federal prosecution.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Court: California cities can ban pot shops

May 06, 2013

(AP)—The California Supreme Court ruled Monday that cities and counties can ban medical marijuana dispensaries, a ruling likely to further diminish the state's once-extravagant network of storefront pot shops and fuel efforts ...

LA council votes to repeal pot dispensary ban

Oct 03, 2012

(AP)—The Los Angeles City Council reversed course Tuesday and repealed a ban on pot shops that it passed just two months ago to shutter hundreds of medical marijuana storefronts.

Recommended for you

Using feminist theory to understand male rape

11 hours ago

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments